AstraZeneca to Buy Alexion Pharmaceuticals for $39 Billion. What to Know
Published
AstraZeneca said Alexion’s expertise will accelerate its growing presence in immunology. The deal is one of the year’s largest drug mergers.
Full ArticlePublished
AstraZeneca said Alexion’s expertise will accelerate its growing presence in immunology. The deal is one of the year’s largest drug mergers.
Full ArticleInvestors don’t seem impressed with AstraZeneca’s (LON: AZN) latest deal, which is also the biggest deal in the company’s..
AstraZeneca plc (LON: AZN) said on Saturday that it will buy Alexion Pharmaceuticals (NASDAQ: ALXN) for £29.50 billion. The..